UC Davis — Research on Antiviral Drugs (Koen Van Rompay)
Verified[Scientific Research] Grant Investigators: Chris Somerville and Heather Youngs This page was reviewed but not written by the grant investigators. UC Davis staff also reviewed this page prior to publication. Open Philanthropy recommended a grant of $170,190 to UC Davis to support a trial led by Koen Van Rompay of an HSP90 inhibitor as a possible treatment for Zika infections in rhesus macaque monkeys. The results of the trial could have implications for the use of HSP90 inhibitors as antiviral treatments in humans. This funding is part of our science team’s effort to explore chaperone inhibitors as broad spectrum, host-directed antiviral drugs. This falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness. The grant amount was updated in May 2022.
Other Grants by Coefficient Giving
2625| Grant | Recipient | Amount | Date |
|---|---|---|---|
| Janaagraha — Air Quality Grants Assessment | $195K | Dec 2024 | |
| Futurewise — Housing Advocacy in Washington | $450K | Apr 2023 | |
| Exscientia — Agonists for Interferon Lambda | $2.3M | Sep 2023 | |
| Kurzgesagt — Short-form Video Content | $3M | Mar 2022 | |
| Kurzgesagt — Video Production (2023) | $1.7M | May 2023 | |
| Kurzgesagt — Video Creation and Translation | $2.6M | Dec 2021 | |
| Lightcone Infrastructure – General Support | Lighthaven (Event Venue) | $4.5M | Sep 2022 |
| Lightcone Infrastructure — General Support (2023) | Lighthaven (Event Venue) | $3M | Oct 2023 |
| Conjecture — Cybersecurity Bootcamp | Conjecture | $223K | Jun 2025 |
| Conjecture — AI Safety Technical Program | Conjecture | $224K | May 2023 |